WO2004099824A2 - Methods and device for non-invasive analyte measurement - Google Patents
Methods and device for non-invasive analyte measurement Download PDFInfo
- Publication number
- WO2004099824A2 WO2004099824A2 PCT/US2004/012893 US2004012893W WO2004099824A2 WO 2004099824 A2 WO2004099824 A2 WO 2004099824A2 US 2004012893 W US2004012893 W US 2004012893W WO 2004099824 A2 WO2004099824 A2 WO 2004099824A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mid
- instrument
- infrared radiation
- radiation
- subject
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 98
- 238000000034 method Methods 0.000 title claims abstract description 77
- 238000005259 measurement Methods 0.000 title description 45
- 230000005855 radiation Effects 0.000 claims abstract description 216
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 239000008103 glucose Substances 0.000 claims description 129
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 108
- 210000001508 eye Anatomy 0.000 claims description 44
- 210000004369 blood Anatomy 0.000 claims description 35
- 239000008280 blood Substances 0.000 claims description 35
- 239000000126 substance Substances 0.000 claims description 34
- 238000004891 communication Methods 0.000 claims description 32
- 210000001519 tissue Anatomy 0.000 claims description 27
- 241000282414 Homo sapiens Species 0.000 claims description 23
- 210000000795 conjunctiva Anatomy 0.000 claims description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 238000010521 absorption reaction Methods 0.000 claims description 14
- 230000005670 electromagnetic radiation Effects 0.000 claims description 13
- 210000003491 skin Anatomy 0.000 claims description 13
- 238000004590 computer program Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000003925 fat Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 6
- 239000003550 marker Substances 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 239000007857 degradation product Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 210000003722 extracellular fluid Anatomy 0.000 claims description 5
- 239000002207 metabolite Substances 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 210000000981 epithelium Anatomy 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 4
- 239000004973 liquid crystal related substance Substances 0.000 claims description 4
- 230000002503 metabolic effect Effects 0.000 claims description 4
- 244000045947 parasite Species 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 239000002243 precursor Substances 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 229940002612 prodrug Drugs 0.000 claims description 4
- 239000000651 prodrug Substances 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 150000008163 sugars Chemical class 0.000 claims description 4
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 108700012359 toxins Proteins 0.000 claims description 4
- 150000003626 triacylglycerols Chemical class 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 210000000845 cartilage Anatomy 0.000 claims description 3
- 210000003195 fascia Anatomy 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 210000004209 hair Anatomy 0.000 claims description 3
- 210000003041 ligament Anatomy 0.000 claims description 3
- 210000004400 mucous membrane Anatomy 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 210000002435 tendon Anatomy 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 2
- 210000001138 tear Anatomy 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 3
- 235000001727 glucose Nutrition 0.000 claims 3
- 230000006855 networking Effects 0.000 claims 1
- 238000001228 spectrum Methods 0.000 abstract description 19
- 238000006424 Flood reaction Methods 0.000 abstract description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 25
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
- 210000001742 aqueous humor Anatomy 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 210000004087 cornea Anatomy 0.000 description 9
- 230000003595 spectral effect Effects 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- 229940125396 insulin Drugs 0.000 description 8
- 230000002596 correlated effect Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 238000005102 attenuated total reflection Methods 0.000 description 5
- 210000004207 dermis Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 231100000673 dose–response relationship Toxicity 0.000 description 4
- 210000000744 eyelid Anatomy 0.000 description 4
- 229960003299 ketamine Drugs 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000003454 tympanic membrane Anatomy 0.000 description 4
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000000624 ear auricle Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229910001120 nichrome Inorganic materials 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 230000005457 Black-body radiation Effects 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 231100000099 dermal / percutaneous penetration testing Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000003786 sclera Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010067671 Disease complication Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910018487 Ni—Cr Inorganic materials 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- HMDDXIMCDZRSNE-UHFFFAOYSA-N [C].[Si] Chemical compound [C].[Si] HMDDXIMCDZRSNE-UHFFFAOYSA-N 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- VNNRSPGTAMTISX-UHFFFAOYSA-N chromium nickel Chemical compound [Cr].[Ni] VNNRSPGTAMTISX-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000009615 fourier-transform spectroscopy Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 235000009643 reducing diet Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- PRZWBGYJMNFKBT-UHFFFAOYSA-N yttrium Chemical compound [Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y][Y] PRZWBGYJMNFKBT-UHFFFAOYSA-N 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006513353A JP2006525084A (ja) | 2003-05-02 | 2004-04-27 | 非侵襲的分析物測定のための方法およびデバイス |
| EP04760590A EP1622507A2 (de) | 2003-05-02 | 2004-04-27 | Verfahren und vorrichtung für die nichtinvasive messung von analyten |
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46735503P | 2003-05-02 | 2003-05-02 | |
| US10/428,410 | 2003-05-02 | ||
| US10/428,410 US6968222B2 (en) | 2003-05-02 | 2003-05-02 | Methods and device for non-invasive analyte measurement |
| US60/467,355 | 2003-05-02 | ||
| US51339603P | 2003-10-21 | 2003-10-21 | |
| US60/513,396 | 2003-10-21 | ||
| US10/824,214 US6975892B2 (en) | 2003-10-21 | 2004-04-14 | Methods for non-invasive analyte measurement from the conjunctiva |
| US10/824,254 US6958039B2 (en) | 2003-05-02 | 2004-04-14 | Method and instruments for non-invasive analyte measurement |
| US10/824,254 | 2004-04-14 | ||
| US10/824,214 | 2004-04-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2004099824A2 true WO2004099824A2 (en) | 2004-11-18 |
| WO2004099824A3 WO2004099824A3 (en) | 2005-01-20 |
Family
ID=33437252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2004/012893 WO2004099824A2 (en) | 2003-05-02 | 2004-04-27 | Methods and device for non-invasive analyte measurement |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1622507A2 (de) |
| JP (1) | JP2006525084A (de) |
| WO (1) | WO2004099824A2 (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9442065B2 (en) | 2014-09-29 | 2016-09-13 | Zyomed Corp. | Systems and methods for synthesis of zyotons for use in collision computing for noninvasive blood glucose and other measurements |
| US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8044354B2 (en) * | 2008-12-04 | 2011-10-25 | The Boeing Company | Method for classifying resins types in carbon fiber reinforced plastic materials using IR spectroscopy |
| US10092209B2 (en) * | 2014-10-03 | 2018-10-09 | Advantest Corporation | Non-invasive in situ glucose level sensing using electromagnetic radiation |
| KR101981632B1 (ko) * | 2017-10-31 | 2019-05-24 | 주식회사 템퍼스 | 혈당 측정 장치 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020049389A1 (en) * | 1996-09-04 | 2002-04-25 | Abreu Marcio Marc | Noninvasive measurement of chemical substances |
| US6418332B1 (en) * | 1999-02-25 | 2002-07-09 | Minimed | Test plug and cable for a glucose monitor |
| US6424851B1 (en) * | 1998-10-13 | 2002-07-23 | Medoptix, Inc. | Infrared ATR glucose measurement system (II) |
| US20030018271A1 (en) * | 2001-07-02 | 2003-01-23 | Kimble Allan Wayne | Simplified and lightweight system for enhanced visualization of subcutaneous hemoglobin-containing structures |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1216409A1 (de) * | 1999-09-17 | 2002-06-26 | Walter K. Proniewicz | Nichtinvasive messung des blutzuckerspiegels |
| DE60223668T2 (de) * | 2001-04-27 | 2008-10-30 | Eyesense Ag | Kit zur messung von blutzuckerkonzentrationen |
| US6836337B2 (en) * | 2001-09-20 | 2004-12-28 | Visual Pathways, Inc. | Non-invasive blood glucose monitoring by interferometry |
-
2004
- 2004-04-27 EP EP04760590A patent/EP1622507A2/de not_active Withdrawn
- 2004-04-27 WO PCT/US2004/012893 patent/WO2004099824A2/en active Application Filing
- 2004-04-27 JP JP2006513353A patent/JP2006525084A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020049389A1 (en) * | 1996-09-04 | 2002-04-25 | Abreu Marcio Marc | Noninvasive measurement of chemical substances |
| US6424851B1 (en) * | 1998-10-13 | 2002-07-23 | Medoptix, Inc. | Infrared ATR glucose measurement system (II) |
| US6418332B1 (en) * | 1999-02-25 | 2002-07-09 | Minimed | Test plug and cable for a glucose monitor |
| US20030018271A1 (en) * | 2001-07-02 | 2003-01-23 | Kimble Allan Wayne | Simplified and lightweight system for enhanced visualization of subcutaneous hemoglobin-containing structures |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9442065B2 (en) | 2014-09-29 | 2016-09-13 | Zyomed Corp. | Systems and methods for synthesis of zyotons for use in collision computing for noninvasive blood glucose and other measurements |
| US9448164B2 (en) | 2014-09-29 | 2016-09-20 | Zyomed Corp. | Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing |
| US9448165B2 (en) | 2014-09-29 | 2016-09-20 | Zyomed Corp. | Systems and methods for control of illumination or radiation collection for blood glucose and other analyte detection and measurement using collision computing |
| US9453794B2 (en) | 2014-09-29 | 2016-09-27 | Zyomed Corp. | Systems and methods for blood glucose and other analyte detection and measurement using collision computing |
| US9459201B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed Corp. | Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing |
| US9459203B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed, Corp. | Systems and methods for generating and using projector curve sets for universal calibration for noninvasive blood glucose and other measurements |
| US9459202B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed Corp. | Systems and methods for collision computing for detection and noninvasive measurement of blood glucose and other substances and events |
| US9610018B2 (en) | 2014-09-29 | 2017-04-04 | Zyomed Corp. | Systems and methods for measurement of heart rate and other heart-related characteristics from photoplethysmographic (PPG) signals using collision computing |
| US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004099824A3 (en) | 2005-01-20 |
| JP2006525084A (ja) | 2006-11-09 |
| EP1622507A2 (de) | 2006-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6968222B2 (en) | Methods and device for non-invasive analyte measurement | |
| US6958039B2 (en) | Method and instruments for non-invasive analyte measurement | |
| US6975892B2 (en) | Methods for non-invasive analyte measurement from the conjunctiva | |
| Do Amaral et al. | Current development in non-invasive glucose monitoring | |
| US20060258918A1 (en) | Combination Analyte Measurement Device and Method of Use | |
| US6430424B1 (en) | Infrared ATR glucose measurement system utilizing a single surface of skin | |
| US20060224057A1 (en) | Methods for non-invasive analyte measurement | |
| US6442410B1 (en) | Non-invasive blood glucose measurement system and method using optical refractometry | |
| EP0828533B1 (de) | Verfahren und vorrichtung zur schnellen unblutigen bestimmung von blut-bestandteeilen | |
| US20020026106A1 (en) | Non-invasive sensor having controllable temperature feature | |
| US20060258920A1 (en) | Non-Invasive Analyte Measurement Glasses and Method of Use | |
| WO2006079797A2 (en) | Apparatus for measurement of analyte concentration | |
| Losoya-Leal et al. | State of the art and new perspectives in non-invasive glucose sensors | |
| EP2254459B1 (de) | Messgerät und verfahren dafür | |
| GB2482378A (en) | Determining analyte concentration using optical assembly interference pattern | |
| EP1622507A2 (de) | Verfahren und vorrichtung für die nichtinvasive messung von analyten | |
| US20080009688A1 (en) | Methods for non-invasive analyte measurement | |
| Mohanram et al. | Measurement of blood glucose using non-invasive methods–a review | |
| US20090240124A1 (en) | Systems and Methods for Measuring the Concentration of Analytes in the Human Eye | |
| US20060258919A1 (en) | Non-Invasive Analyte Measurement Device for Measuring Tears and Other Ocular Elements Using Electromagnetic Radiation and Method of Using the Same | |
| Talukdar | Non-Invasive Measurement of Glucose Content in Human Body: A Comparative Study | |
| Khan et al. | Non-Invasive Blood Glucose Measurement Device: Performance analysis of Diffused Reflectance method and Diffused Transmittance method using Near Infrared Light | |
| Ben-David et al. | Noninvasive glucose monitoring | |
| Ali | FEASIBILITY STUDY ON DEVELOPING AN OPTICAL FIBRE-BASED, NON-INVASIVE, ELECTRO-TEXTILE SENSOR FOR DETECTING BLOOD GLUCOSE | |
| MXPA01003773A (en) | Infrared atr glucose measurement system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2004760590 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2006513353 Country of ref document: JP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2004760590 Country of ref document: EP |